Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


2nd Annual Biosimilars & Biobetters Congress 2014

03 Apr 2014 - 04 Apr 2014



Bookmark and Share


Over 400 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

25 presentations, case studies and panel discussions focused on the key issues in follow-on biologics development and commercialisation

2 interactive streams:

  • Market Opportunities and Commercial Challenges
  • Developing Biosimilars and Biobetters

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Co-located with the 7th Annual Proteins & Antibodies Congress & the Peptides Congress Oxford Global are proud to present the Biosimilars & Biobetters Congress, taking place on 3-4 April 2014 at Novotel London West, UK.

The follow on biologics industry is forecast to reach $8.8 billion by 2017. Our conference programme focuses on the challenges, innovations and technologies that promise to put this sector at the forefront of the pharmaceutical industry.

The 2nd Annual Biosimilars and Biobetters Congress features two streams:

Market Opportunities & Commercial Challenges: In Stream 1, the meeting will address the most pressing challenges in gaining access to emerging markets and branding biosimilars through a series of cutting-edge conference presentations. Our boisimilars experts will also debate how to overcome regulatory challenges, outsource manufacturing and develop pricing strategies

Developing Biosimilars & Biobetters: Learn more about current developments in clinical trials, including pharmacovigilence and patient safety. Do not miss out on the chance to discover innovative solutions for achieving quality by design, demonstrating biosimilarity and addressing potency as well as the latest insights into the regulatory requirements and trial design.

The Biosimilars & Biobetters Congress is part of the highly successful Oxford Global Proteins Series.

Further information
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!